tbuckley/cabot-search huggingface dataset:
Röntgentherapie. Oberflächen- und Tiefenbestrahlung.
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Paroxysmal Atrial Fibrillation in a Physically Active Man: Treatment Concerns
Journal: JAMA (1988)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Poor quality of life in women with chest pain and normal angiograms: The NHLBI-sponsored WISE study Marian B. Olson, C. Noel Bairey Merz, Barry Sharaf, Sheryl F. Kelsey, Gerald Pohost, Diane Vido, Karen Matthews, Carol Cornell, Angela Cardello, Susan McGorray. University of Pittsburgh, Pittsburgh, PA
Journal: Journal of the American College of Cardiology (2001)
Shock II
Authors: G. J. Wolbink, J. W. Baars, J. Wagstaff, A. Eerenberg, C. E. Hack, R. W. Faint, M. Mythen, I. J. Mackie, S. J. Machin, C. Routsi, S. Zakynthinos, B. Haviaras, A. Mavromatis, A. Armaganidis, B. Kadas, Ch. Roussos, D. Annane, M. C. Jars-Guincestre, F. Paraire, J. C. Raphaël, L. Lind, J. Mälstam, G. Skoog, J. -L. Teboul, J. Depret, N. Leger, D. Douguet, M. Zelter, A. Mercat, Ch. Richard, F. Saulnier, A. Durocher, G. Cadelis, F. Herengt, F. Wattel, B. Kugler, K. Träger, M. Holland, Th. Schricker, M. Georgieff, R. G. J. Westendorp, A. N. Roos, R. Simons, M. Frölich, A. E. Meinders, M. Lichtwarck-Aschoff, J. Aschenbrenner, G. Zimmermann, R. Senekowitsch, U. J. Pfeiffer, G. Blümel, A. T. Lovell, G. C. Hanson, P. J. Jensen, P. K. Andersen, C. Thøgersen, J. I. Poelaert, J. A. Everaert, D. P. Vogelaers, J. M. Decruyenaere, F. A. Colardyn, A. C. Timmins, M. Giles, C. J. Hinds, N. Maynard, D. Bihari, R. Mason, G. Baldock, I. McColl, D. Mathieu, R. Neviere, M. Fleyfel, J. Zaknun, L. Fridrich, D. Heute, S. Dyrk, A. Stoeger, M. Seyr, N. Mutz, G. Riccabona, J. Y. Lefrant, G. Aya, J. E. de la Coussaye, B. Bassoul, J. P. Auffray, J. J. Eledjam, S. Leucht, H. W. Kisch, R. Goller, J. P. Belot, B. Valtier, D. Mottin, D. Payen, A. Rubini, Del Monte, I. Attar, E. Catena, G. Rattazzi, G. L. Alati, P. Polisca, F. Turani, M. D. Pierri, L. Sommariva, Peppo A. de Penta, D. F. Colella, E. Zupancich, P. A. Gioffrè, L. Chiariello, A. Descorps-Declère, J. Hollande, M. Beaussier, O. Mimoz, J. Duranteau, A. Edouard, K. Samii, F. Saulnier, J. N. Drault, P. Marzollo, P. Sebastiano, M. Mariotti, P. Burnier, R. Chioléro, J. -J. Goy, Y. Schütz, H. Gombotz, H. Metzler, J. Plaza, J. Berger, W. F. List, D. C. Angus, N. M. Lidsky, L. M. Dotterweich, M. R. Pinsky, P. Evrard, B. de Ruyter, A. Dive, M. Gonzalez, L. Jacquet, E. Installé
Journal: Intensive Care Medicine (1992)
Why not scientific administration?
Authors: G. D. Lundberg
Journal: JAMA (1983)

Physicians are practitioners of the art and science of medicine. Academic and practicing medical leaders and editors insist on the best possible data prior to drawing conclusions and taking actions. In those roles, we dogmatically adhere to the great desirability of prospective, randomized, double-blind clinical trials with numbers great enough to ensure statistical power. We use anonymous referees to exert true academic rigor and expert biostatisticians to critique the experimental design, validity of data, and conclusions prior to publishing any important scientific article. Clinicians in practice, researchers, teachers, house officers, and medical students teach, are taught, and live by such critical rigor of scientific method applicable to patient care decisions. Then how is it that these same groups of people will tolerate the creation and application of laws, regulations, standards, and guidelines that have an immense impact on the practice of medicine when virtually no scientific method has been applied?
Expression of hypoxia-inducible factor-1 alpha is associated with an unfavorable prognosis in non-small cell lung cancer
Authors: Y. Fujita, Y. Nishigaki, M. Aoki, M. Sato, Y. Yamamoto, A. Takeda, Y. Yamazaki, H. Aoki, A. Nagase, S. Fujiuchi
Journal: Journal of Clinical Oncology (2004)

7147 Background: Hypoxia-inducible factor (HIF) -1alpha is a transcription factor that mediates adaptive responses of human cells in tissue hypoxia. HIF-1alpha activates various factors supporting tumor growth and progression. HIF-1alpha expression in patients with non-small cell lung cancer (NSCLC), however, has not been well studied. The aim of this study was to determine the expression of HIF-1alpha protein and its relation to clinicopathologic features and prognosis of patients with NSCLC. Methods: We studied retrospectively expression of HIF-1alpha protein in 139 patients with NSCLC by immunohistochemistry. Nuclear expression of HIF-1alpha was measured by observing 1000 cancer cells. The percentage of positive cells was rated as follows: negative expression, cases with <10% positive cells; weak expression, 10–50% positive cells; moderate expression, 50.1–80% positive cells; and strong expression, cases with 80% positive cells. Expression of HIF-1alpha was compared in relation to clinicopathologic findings. Results: HIF-1alpha expression ranged from 0 to 98.8% with a mean value of 41.8%. Forty-two patients (30.2%) showed negative expression, 37 patients (26.6%) showed weak expression, 32 patients (23%) showed moderate expression, and 28 patients (20.1%) showed strong expression. HIF-1alpha expression showed significant correlation with histology, pT status, or pathological stage (p=0.0012, p=0.0097, p=0.008, respectively). Five-year survival rates of negative expression group, weak expression group, moderate expression group and strong expression were 80.2%, 68.4%, 40%, and 20.5%, respectively (p<0.0001, log-rank test). A multivariate analysis of survival time by the stepwise procedure revealed that pathological stage and HIF-1alpha expression were statistically significant prognostic factors (p<0.0001, p=0.0002, respectively). Conclusions: This study shows that HIF-1alpha may be an independent prognostic factor, which can indicate the subsets of patients with poor prognosis, in patients with NSCLC who underwent surgical resection. No significant financial relationships to disclose.
Umbilical Vein Catheterization as Cause of Portal Thrombosis and Portal Hypertension
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Children’s Brain Tumour Drug Delivery Consortium
Authors: Dr Emma Campbell, Prof David Walker, Dr Ruman Rahman, Prof Richard Grundy, Prof Henry Brem, Dr Monica Pearl, Dr Jordan Green, Dr Miroslaw Janowski, Prof Kenneth Cohen, Dr Piotr Walczak, Dr Katherine Warren, Dr Stephen Lowis, Prof Alexander Mullen, Dr Marie Boyd, Dr Gareth Veal, Prof Darren Hargrave, Dr Dannis Van Vuurden, Dr Steven Powell
Journal: Neuro-Oncology (2018)

There is an urgent need to expedite the development of new or repurposed drugs for children’s cancer. An additional challenge in the developing brain is to ensure the drug is delivered to the tumour at therapeutic and non-toxic concentrations for sufficient duration to achieve the biological effect. Children’s brain tumours account for over 20% of childhood cancers and differ significantly in their biological characteristics from their adult counterparts. The authors participated in an international CNS drug delivery workshop funded by the charity Children with Cancer UK in February 2016, where different experimental techniques aimed at optimising CNS drug delivery in children’s brain tumours were discussed. The workshop was reported by e-cancer (http://ecancer.org/journal/10/full/630-highlights-of-children-with-cancer-uk-s-workshop-on-drug-delivery-in-paediatric-brain-tumours.php; http://ecancer.org/conference/831-drug-delivery-in-paediatric-brain-tumours.php). We were encouraged to develop a proposal to establish an international research consortium to raise awareness and promote collaboration in the field. This is now funded for two years by Children with Cancer UK. The Children’s Brain Tumour Drug Delivery Consortium seeks to strengthen collaborative developments by working closely with the international children’s brain tumour community, encouraging and facilitating discussions between a multi-disciplinary network of clinicians and researchers within pharma and academia as well as a range of funders and stakeholders. As of March 2018, we have 94 individuals from 11 nations registered as members, with diverse stakeholders represented by academics, clinical academics, charities, public/patient groups, industry and regulatory bodies. We present this abstract to the BNOS conference to raise awareness of this initiative with the large number of relevant stakeholders who will be attending the event, and to extend our invitation for collaborators to join the consortium.
Domestic Abstracts
Journal: JAMA (1986)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Firearms and fatalities
Authors: J. S. Ferguson
Journal: JAMA (1996)

<h3>In Reply.</h3> —Dr Blackman suggests that the public health paradigm may not be appropriate for motor vehicle crashes and may not be applicable to firearm injuries. We think the public health paradigm is useful for organizing information and identifying prevention strategies along logical and consistent lines. This epidemiologic triad helps us view deaths and injuries as resulting from interactions of the host, vehicle/ agent, and environment. Deaths and injuries can be reduced by changing the relationship of these factors, and the reduced speed limits and improved emergency medical responses that Blackman mentions are good examples of how changes in the environment affect motor vehicle crash injuries. Changes in vehicular design, including air bags, seat belts, and crashworthy occupant compartments, and constructive changes in human behavior by reduced drunk driving have further contributed to the reduction in motor vehicle crash deaths and form the second and third parts of the triad.
A Manual of Materia Medica and Pharmacology. Comprising all Organic and Inorganic Drugs, which are and have been Official in the United States Pharmacopeia, together with important Allied Species and Useful Synthetics. For Students of Medicine, Druggists, Pharmacists and Physicians.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Piece of My Mind
Journal: JAMA (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SUICIDE BY SUGGESTION AND LIFE INSURANCE.
Journal: JAMA (1897)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Impact of Lenalidomide Plus Low-Dose Dexamethasone Treatment on Immune Cell Populations of the Patients with Refractory/Relapsed Multiple Myeloma
Authors: Sung-Eun Lee, Ji-Young Lim, Da-Bin Ryu, Tae Woo Kim, Young-Woo Jeon, Jae-Ho Yoon, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Dong-Wook Kim, Jong Wook Lee, Woo-Sung Min, Chang-Ki Min
Journal: Blood (2015)
AMAGRAMS
Journal: JAMA (1971)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Message from the New Editor-in-Chief
Authors: George C. Prendergast
Journal: Cancer Research (2010)

Cancer Research is the flagship publication of one of the largest scientific societies in the field and its most frequently cited journal. This exceptional resource has a long history of communicating studies of broad interest and high impact in basic, translational, and clinical aspects of oncology. Building on the outstanding leadership of the previous Editor-in-Chief and his team, the new editorial team seeks to continue to expand the breadth, influence, and quality of the journal, which is well situated to extend its stature as the field's leading scientific society journal.A key strength of Cancer Research is the interest of its content to the field as a whole, which encompasses a broad and diverse readership. Looking to the future, the incoming editorial team will continue to focus on publishing studies with the highest impact and broadest significance. We will also offer other content and editorial improvements to assist readers in gaining a cross-disciplinary grasp of diverse areas of the field. We will deepen the general core excellence in pathobiology, particularly in the exciting and rapidly growing areas of tumor microenvironment and immunology, capturing the most seminal work. Overall, the editorial team will work to continue the tradition of Cancer Research as the cancer community's most vital publication, strengthening its focus on broad-reaching, high-impact studies that inform solutions to the personal, clinical, and societal problems posed by cancer.The new editorial team has been expanded and rebalanced to reflect priorities for the journal as well as areas of expertise where submissions are received and distributed. Changes have been made in the categories for submission and in the number of editors in each category to improve editorial efficiencies. In particular, the number and balance in expertise of the Senior Editors and Editorial Board members who handle manuscripts has been matched more closely to the category in which manuscripts are received. By reducing the workload in high submission categories, this change should help enhance review efficiency. The roles and responsibilities for the different editors of the journal are as follows:Cancer Research has matured to become a highly translational enterprise. It is exciting to behold the field as it enters what may be a golden age of applications of modern concepts to create dramatic clinical improvements in cancer diagnosis, prognosis, and treatment. For those who seek the elimination of the scourge of disease, Cancer Research will continue to serve as the leading venue for publishing high-impact findings of the broadest significance to the field, along with other content to enlighten and integrate the field's efforts to change the fate of those suffering from cancer.
Nutrition and society
Authors: D. J. Kallen
Journal: JAMA (1971)

Malnutrition during development leads to high infant mortality and lowered physical size. While severe malnutrition may lead to intellectual impairment, the direct relationship between moderate malnutrition and intelligence is still unknown. This is because both nutrition and intellectual development are associated with various social factors. While malnutrition is a medical problem, hunger is a social problem, complicated by the fact that the hungry are also subject to various other noxious social conditions. The negative effect of moderate malnutrition may stem from apathy in learning and other situations which relate to life success.